November 26, 2025 - 05:46

Fujitsu has introduced a groundbreaking technology designed to swiftly and accurately measure blue carbon, the carbon sequestered by marine and coastal ecosystems such as seaweed and seagrass. This advancement plays a crucial role in the restoration and preservation of seagrass beds, vital components of marine biodiversity and carbon storage.
The new technology is an integral part of Fujitsu's ongoing research into ocean digital twin technology, which aims to create virtual representations of ocean environments. By utilizing this innovative approach, the certification process for blue carbon credits can be significantly expedited. This is particularly important as blue carbon initiatives are essential for combating climate change and promoting marine environmental health.
With this development, Fujitsu is positioning itself at the forefront of efforts to enhance the effectiveness of blue carbon projects, thereby contributing to global decarbonization goals and the sustainable management of ocean resources. The implications of this technology extend beyond carbon credits, potentially fostering a healthier marine ecosystem for future generations.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...